deepc Secures $13M Series A Extension to Enhance Radiology AI Platform
deepc aims to redefine the use of artificial intelligence in radiology, making it simpler for healthcare providers to adopt and benefit from the latest AI innovations.
Company Name: deepc
Location: Munich, Germany
Sector: Healthcare Technology, Artificial Intelligence
Funding Details: Closed a $13M extension in Series A funding, bringing the total raised in this round to $30M. The investment was led by Sofinnova Partners and Bertelsmann Investments, with participation from new investors KHP Ventures and SwissHealth Ventures, as well as existing investor Winning Mindset Ventures.
Purpose of Investment: To accelerate growth, expand internationally, and further enhance and commercialize deepcOS®, the company's industry-leading radiology AI operating system.
Leadership: Led by CEO Dr. Franz Pfister.
Product and Innovation: deepcOS® is a cutting-edge AI operating system tailored for radiologists and enterprise clinical organizations. It offers clinicians seamless access to a wide array of regulatory-approved AI solutions that cover over 60 clinical indications. This platform significantly enhances workflow efficiency and supports radiologists in their daily tasks by integrating advanced AI tools directly into their operational processes.
Company Growth: deepc is dedicated to transforming radiology through advanced technology. The platform facilitates the installation, end-to-end integration, and management of AI applications, streamlining contracting, billing, and service processes under a robust privacy and security framework.
About the Company: deepc aims to redefine the use of artificial intelligence in radiology, making it simpler for healthcare providers to adopt and benefit from the latest AI innovations. The company’s solutions improve diagnostic accuracy, reduce time pressures on radiologists, and enhance patient outcomes.
Future Plans: With the new funding, deepc plans to expand its reach into new markets and continue developing its platform to meet the growing demands of the healthcare industry globally. This will include scaling operations, enhancing product features, and broadening the scope of its AI solutions to support more clinical needs.
